Real World Perspective: Evidence Shaping the Treatment of Severe Keratitis in Dry Eye Disease
Date: 29/03/2023 (ACDT)
Venue: National Wine Centre of Australia, Corner of Hackney & Botanic Roads, SA 5000
Provider: CSL Seqirus
Contact: Daniel Yu, [E] daniel.yu@seqirus.com, [P] 0427 769 539
Learning Objectives
- Understand how to escalate treatment in patients with dry eye disease with severe keratitis with ciclosporin eye drops.
- Gain insight into the relevance of real-world evidence to help guide the practical management of patients with ciclosporin eye drops, specifically Ciclosporin 0.1% eye drops.
- Know the pathways for applying for PBS Authority application for Ikervis (ciclosporin 0.1% eye drops), where eligible.
Max CPD hours awarded: 1.5
Session Information
Name |
---|
A closer look at ciclosporin eye drops & Ikervis® case studies in Australia |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.5 |
Name |
---|
PERSPECTIVE Study: Real-World Evidence of Ikervis® effectiveness, tolerability and safety |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.5 |
Name |
---|
Live Q & A Panel: Real world insights |
Clinical? |
Yes |
Interactive? |
No |
Therapeutic? |
Yes |
Duration of CPD Session/Module |
0.5 |
Duration of CPD Session/Module inclusive of Assessment Component |
0.5 |